Topical Fat-Burning Cream, Supported by Science

Reduce local fat and cellulite by inhibiting the enzyme 11 beta hydroxysteroid dehydrogenase type I by glycerrhitinic acid (GA). This allows GA to minimize the action of cortisol while aminophylline lowers the threshold of fat cells- making them more vulnerable to the fat burning effects of GA.

This is a spot reduction fat loss cream that has shown promising results placebo controlled scientific studies. In two separate studies, one showed an average loss of 11cm off the waist after 3 months of application. Another showed a significant reduction in the superficial fat layer depth and circumference when applied to the thigh.